Valeant Pharmaceuticals Slides As CEO Takes Medical Leave Of AbsenceRupert Hargreaves
Shares in Valeant Pharmaceuticals are sliding today after the company confirmed the rumors that its CEO Michael Pearson will be on a medical leave of absence effective immediately as he undergoes treatment for a severe case of pneumonia.
At time of writing, Valeant's shares had fallen by 9.3% in early trading after the release of this news. The company has announced that in Mr. Pearson's absence, it has created an Office of the Chief . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.